154 related articles for article (PubMed ID: 10071508)
1. [Gastric MALT lymphoma, clinical features].
Udvardy M
Orv Hetil; 1999 Feb; 140(6):291-4. PubMed ID: 10071508
[TBL] [Abstract][Full Text] [Related]
2. Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
Cammarota G; Tursi A; Cannizzaro O; Papa A; Cuoco L; Cianci R; Fedeli P; Fedeli G; Gasbarrini G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):361-4. PubMed ID: 9476192
[TBL] [Abstract][Full Text] [Related]
3. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
4. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori.
Kume K; Hirakoba M; Murata I; Yoshikawa I; Otsuki M
Am J Gastroenterol; 2001 Sep; 96(9):2796-7. PubMed ID: 11569719
[No Abstract] [Full Text] [Related]
5. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
6. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
7. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
[TBL] [Abstract][Full Text] [Related]
8. [Gastric MALT lymphoma, a malignancy potentially curable by eradication of Helicobacter pylori].
Delchier JC
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):453-8. PubMed ID: 12700502
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
[TBL] [Abstract][Full Text] [Related]
10. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.
Kim YS; Kim JS; Jung HC; Lee CH; Kim CW; Song IS; Kim CY
J Gastroenterol; 2002 Jan; 37(1):17-22. PubMed ID: 11824795
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
[TBL] [Abstract][Full Text] [Related]
12. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.
Morgner A; Miehlke S; Fischbach W; Schmitt W; Müller-Hermelink H; Greiner A; Thiede C; Schetelig J; Neubauer A; Stolte M; Ehninger G; Bayerdörffer E
J Clin Oncol; 2001 Apr; 19(7):2041-8. PubMed ID: 11283137
[TBL] [Abstract][Full Text] [Related]
13. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.
Sackmann M; Morgner A; Rudolph B; Neubauer A; Thiede C; Schulz H; Kraemer W; Boersch G; Rohde P; Seifert E; Stolte M; Bayerdoerffer E
Gastroenterology; 1997 Oct; 113(4):1087-90. PubMed ID: 9322502
[TBL] [Abstract][Full Text] [Related]
14. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
[TBL] [Abstract][Full Text] [Related]
15. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
[TBL] [Abstract][Full Text] [Related]
16. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma.
Neubauer A; Thiede C; Morgner A; Alpen B; Ritter M; Neubauer B; Wündisch T; Ehninger G; Stolte M; Bayerdörffer E
J Natl Cancer Inst; 1997 Sep; 89(18):1350-5. PubMed ID: 9308704
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Helicobacter pylori in gastric MALT-type lymphoma: differences between histologic and serologic diagnosis.
Eck M; Greiner A; Schmausser B; Eck H; Kolve M; Fischbach W; Strecker P; Müller-Hermelink HK
Mod Pathol; 1999 Dec; 12(12):1148-51. PubMed ID: 10619268
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy.
Cammarota G; Tursi A; Montalto M; Papa A; Branca G; Vecchio FM; Renzi C; Verzí A; Armuzzi A; Pretolani S
J Clin Gastroenterol; 1995 Sep; 21(2):118-22. PubMed ID: 8583076
[TBL] [Abstract][Full Text] [Related]
20. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
